In the history of cancer treatment, Yale is perhaps best known as the institution where cancer chemotherapy and the entire field of cancer drug development was discovered and the very first cancer drug was administered in 1942. In 1953 Yale created the first department of pharmacology, the precursor to the section of medical oncology, to focus on cancer drug development and treatment. Yale Cancer Center became an inaugural National Cancer Institute Comprehensive Cancer Center in 1974 under the National Cancer Act.
Building on our long and rich tradition of excellence in clinical care, research, and training in oncology, we offer comprehensive clinical care and research. The section’s nationally and internationally renowned faculty are leaders in their areas of research and clinical expertise, and are committed to advancing the science and practice of oncology by understanding the molecular basis of disease, and translating basic discoveries to the clinic.
Everyone8:00 AM12:00 PMW. Mark Saltzman, PhD - William J. Catalona, MD - John A. Libertino, MD - Michael S. Leapman, MD, MHS - Robert M. Weiss, MD, FACS, FAAP - Darryl T. Martin, PhD - Vito Imbasciani, PhD, MD, FACS - Patrick C. Walsh, MD Everyone7:30 PM8:00 PMRoy S. Herbst, MD, PhD - Preston C. Sprenkle, MD - Preston C. Sprenkle, MDWNPR 90.5 Everyone7:30 AM9:00 AM Everyone10:00 AM10:30 AMMeeting ID: 920 7574 7723 Passcode: 256101 Everyone10:00 AM11:00 AMAcadia Kocher